Condition
Cancer Distress
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT05302583Not ApplicableRecruitingPrimary
Aromatherapy Inhaler Use for HSCT Distress
NCT07009093Not ApplicableRecruiting
Utility of a Mobile Application for Young Women With Breast Cancer
NCT03215199Not ApplicableRecruitingPrimary
Northern Alberta Psychosocial Telecare (NAPT) Screening for HNC Patients
Showing all 3 trials